Published in Women's Health Weekly, August 18th, 1997
Scheduled to become available in late 1997, the gel is indicated for treatment of secondary amenorrhea, the absence of the monthly menstrual cycle in reproductive age women who have experienced regular cycles in the past. Previously, the higher dosage strength of Crinone 8% gel received marketing clearance for use in conjunction with infertility treatment.
Common factors that may contribute to secondary amenorrhea include weight loss, regular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.